Compare AVXL & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | RCKY |
|---|---|---|
| Founded | 2004 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.1M | 273.7M |
| IPO Year | 2013 | 1996 |
| Metric | AVXL | RCKY |
|---|---|---|
| Price | $3.16 | $36.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $22.00 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 852.5K | 61.4K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | N/A | ★ 94.74 |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $270,408,000.00 |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | ★ N/A | $213.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.61 | $20.28 |
| 52 Week High | $13.99 | $48.70 |
| Indicator | AVXL | RCKY |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 35.32 |
| Support Level | $2.93 | $27.77 |
| Resistance Level | $3.76 | $44.83 |
| Average True Range (ATR) | 0.19 | 1.72 |
| MACD | 0.01 | -0.76 |
| Stochastic Oscillator | 12.23 | 16.75 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.